enGene Holdings Inc. (ENGNW)
NASDAQ: ENGNW · Real-Time Price · USD
0.5900
-0.0500 (-7.81%)
Apr 1, 2025, 2:52 PM EDT - Market closed

enGene Holdings Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jan '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
Selling, General & Admin
25.4923.989.63.963.413.24
Research & Development
52.6538.3216.4615.4712.4610.61
Operating Expenses
78.1462.326.0619.4315.8713.85
Operating Income
-78.14-62.3-26.06-19.43-15.87-13.85
Interest Expense
-2.99-2.8-4.95-1.42-5.02-3.7
Interest & Investment Income
12.1210.411.120.130.030.06
Currency Exchange Gain (Loss)
-0.01-0.11-0.13-0.7-0.1-0.1
Other Non Operating Income (Expenses)
---10.57-3.02-4.20.97
EBT Excluding Unusual Items
-69.02-54.8-40.6-24.44-25.17-16.63
Other Unusual Items
--0.37-59.3-1.731.56
Pretax Income
-69.02-55.16-99.9-24.44-23.44-15.07
Income Tax Expense
0.03-0.020.020.02--
Net Income
-69.05-55.14-99.92-24.46-23.44-15.07
Preferred Dividends & Other Adjustments
--4.824.56-1.191.58
Net Income to Common
-69.05-55.14-104.74-29.02-22.25-16.65
Shares Outstanding (Basic)
45381143
Shares Outstanding (Diluted)
45381143
Shares Change (YoY)
606.66%5355.08%5.72%-81.61%28.93%-
EPS (Basic)
-1.54-1.46-151.22-44.30-6.25-6.02
EPS (Diluted)
-1.54-1.46-151.22-44.30-6.25-6.02
Free Cash Flow
-67.33-49.21-25.06-17.75-16.23-13.25
Free Cash Flow Per Share
-1.50-1.30-36.18-27.09-4.56-4.80
EBITDA
-78.02-62.21-25.89-19.19-15.6-13.59
D&A For EBITDA
0.110.090.180.240.270.26
EBIT
-78.14-62.3-26.06-19.43-15.87-13.85
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.